These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31021394)

  • 1. Optimal timing of hepatitis B virus DNA quantification and clinical predictors for higher viral load during pregnancy.
    Cheung KW; Seto MTY; So PL; Wong D; Mak ASL; Lau WL; Wang W; Kan ASY; Lee CP; Ng EHY
    Acta Obstet Gynecol Scand; 2019 Oct; 98(10):1301-1306. PubMed ID: 31021394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical study on blocking mother-to-child transmission of hepatitis B virus with high viral load and HBeAg positivity during pregnancy in Guizhou province].
    Zhang BF; Cheng ML; Zhang Q; Zhao XK; Yu L; Yang J; Deng KS; Zhang LS; Wang J; Hu YX
    Zhonghua Gan Zang Bing Za Zhi; 2018 Dec; 26(12):945-950. PubMed ID: 30669789
    [No Abstract]   [Full Text] [Related]  

  • 3. Mother-to-child transmission of hepatitis B: Examining viral cut-offs, maternal HBsAg serology and infant testing.
    Thilakanathan C; Wark G; Maley M; Davison S; Lawler J; Lee A; Shackel N; Nguyen V; Jackson K; Glass A; Locarnini SA; Levy MT
    Liver Int; 2018 Jul; 38(7):1212-1219. PubMed ID: 29532580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Identification of risk factors related to the failure of immunization to interrupt hepatitis B virus perinatal transmission].
    Yin YZ; Zhou J; Zhang PZ; Hou HY
    Zhonghua Gan Zang Bing Za Zhi; 2013 Feb; 21(2):105-10. PubMed ID: 23663881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal hepatitis B e antigen can be an indicator for antiviral prophylaxis of perinatal transmission of hepatitis B virus.
    Lu Y; Song Y; Zhai X; Zhu F; Liu J; Chang Z; Li Y; Xiao Y; Li L; Liu M; Liu J; Duan Z; Zou H; Zhuang H; Wang J; Li J
    Emerg Microbes Infect; 2021 Dec; 10(1):555-564. PubMed ID: 33682609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The maternal viral threshold for antiviral prophylaxis of perinatal hepatitis B virus transmission in settings with limited resources: A large prospective cohort study in China.
    Lu Y; Zhu FC; Liu JX; Zhai XJ; Chang ZJ; Yan L; Wei KP; Zhang X; Zhuang H; Li J
    Vaccine; 2017 Dec; 35(48 Pt B):6627-6633. PubMed ID: 29079104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of quantitative hepatitis B virus surface antigen testing in pregnancy in predicting vertical transmission risk.
    Samadi Kochaksaraei G; Congly SE; Matwiy T; Castillo E; Martin SR; Charlton CL; Coffin CS
    Liver Int; 2016 Nov; 36(11):1604-1610. PubMed ID: 27059287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic hepatitis B in pregnant women: is hepatitis B surface antigen quantification useful for viral load prediction?
    Fujiko M; Chalid MT; Turyadi ; Ie SI; Maghfira ; Syafri ; Wahyuni R; Roni M; Patellongi I; Massi MN; Muljono DH
    Int J Infect Dis; 2015 Dec; 41():83-9. PubMed ID: 26571304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective interventional study of tenofovir in pregnancy to prevent vertical transmission of hepatitis B in highly viremic women.
    Sellier PO; Maylin S; Berçot B; Chopin D; Lopes A; Simoneau G; Evans J; Delcey V; Bénifla JL; Simon F; Bergmann JF
    Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):259-263. PubMed ID: 27879486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the use of Tenofovir Dipivoxil fumarate effective and safe in preventing vertical transmission in pregnant women with chronic HBV with high viral load?
    Aladag H; Aladag M
    Eur Rev Med Pharmacol Sci; 2023 Mar; 27(5):2091-2098. PubMed ID: 36930508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical characteristics of hepatic flare and efficacy of antiviral therapy in pregnant women with chronic hepatitis B virus infection].
    Ding Y; Sheng QJ; Zhang C; Wu YY; Yuan SY; Xia TT; An ZY; Dou XG
    Zhonghua Gan Zang Bing Za Zhi; 2019 Feb; 27(2):106-111. PubMed ID: 30818914
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection.
    Celen MK; Mert D; Ay M; Dal T; Kaya S; Yildirim N; Gulsun S; Barcin T; Kalkanli S; Dal MS; Ayaz C
    World J Gastroenterol; 2013 Dec; 19(48):9377-82. PubMed ID: 24409065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telbivudine prevents vertical transmission of hepatitis B virus from women with high viral loads: a prospective long-term study.
    Wu Q; Huang H; Sun X; Pan M; He Y; Tan S; Zeng Y; Li L; Deng G; Yan Z; He D; Li J; Wang Y
    Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1170-6. PubMed ID: 25251571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with mother-to-child transmission of hepatitis B virus despite immunoprophylaxis.
    Liu CP; Zeng YL; Zhou M; Chen LL; Hu R; Wang L; Tang H
    Intern Med; 2015; 54(7):711-6. PubMed ID: 25832930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen.
    Jourdain G; Ngo-Giang-Huong N; Cressey TR; Hua L; Harrison L; Tierney C; Salvadori N; Decker L; Traisathit P; Sirirungsi W; Khamduang W; Bowonwatanuwong C; Puthanakit T; Siberry GK; Watts DH; Murphy TV; Achalapong J; Hongsiriwon S; Klinbuayaem V; Thongsawat S; Chung RT; Pol S; Chotivanich N
    BMC Infect Dis; 2016 Aug; 16():393. PubMed ID: 27506549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B.
    Jourdain G; Ngo-Giang-Huong N; Harrison L; Decker L; Khamduang W; Tierney C; Salvadori N; Cressey TR; Sirirungsi W; Achalapong J; Yuthavisuthi P; Kanjanavikai P; Na Ayudhaya OP; Siriwachirachai T; Prommas S; Sabsanong P; Limtrakul A; Varadisai S; Putiyanun C; Suriyachai P; Liampongsabuddhi P; Sangsawang S; Matanasarawut W; Buranabanjasatean S; Puernngooluerm P; Bowonwatanuwong C; Puthanakit T; Klinbuayaem V; Thongsawat S; Thanprasertsuk S; Siberry GK; Watts DH; Chakhtoura N; Murphy TV; Nelson NP; Chung RT; Pol S; Chotivanich N
    N Engl J Med; 2018 Mar; 378(10):911-923. PubMed ID: 29514030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of telbivudine to prevent mother-to-child transmission of hepatitis B virus in middle- and late-stage pregnancy with high viral loads.
    Xu J; Tao LL; Ma LX
    J Med Virol; 2019 Dec; 91(12):2153-2157. PubMed ID: 31397488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus serosurvey and awareness of mother-to-child transmission among pregnant women in Shenyang, China: An observational study.
    Sheng QJ; Wang SJ; Wu YY; Dou XG; Ding Y
    Medicine (Baltimore); 2018 Jun; 97(22):e10931. PubMed ID: 29851831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with vaccine failure and vertical transmission of hepatitis B among a cohort of Canadian mothers and infants.
    Singh AE; Plitt SS; Osiowy C; Surynicz K; Kouadjo E; Preiksaitis J; Lee B
    J Viral Hepat; 2011 Jul; 18(7):468-73. PubMed ID: 20546502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of perinatal hepatitis B transmission in Haimen City, China: Results of a community public health initiative.
    Evans AA; Cohen C; Huang P; Qian L; London WT; Block JM; Chen G
    Vaccine; 2015 Jun; 33(26):3010-5. PubMed ID: 25698491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.